hamburger-icon
close-icon

invest-iconInvest

trade-iconTrade

depository-iconInsurance

watch-iconPMS

depository-iconTrading Platforms

depository-iconDepository

watch-iconWatch Markets

depository-iconFPI

watch-iconMerchant Banking

watch-iconInstitutional Broking

watch-iconMTF

partner-iconBecome a Partner

partner-iconKnowledge Center

watch-iconResearch

about-iconAbout Us

support-iconSupport

support-iconPricing

support-iconQuick Links

support-iconBlog

hamburger-icon
close-icon

Arihant Capital Markets Ltd

  • BSE Code : 511605
  • NSE Symbol : ARIHANTCAP
  • ISIN : INE420B01036
  • Industry :FINANCE & INVESTMENTS
Trade Now

up-arrow 60.45 -0.35(-0.58%)

Open Price (₹)

60.80

Prev. Close (₹)

60.80

Volume (No’s)

143,812

Market Cap (₹)

633.01

Low Price (₹)

59.90

High Price (₹)

61.45

 

Board Meetings

Start Date End Date Purpose
23-Jan-2024 03-Feb-2024 ARIHANT CAPITAL MARKETS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 inter alia to consider and approve 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31 2023. 2. To reconstitute the committees of the company i.e. Audit Committee Nomination Remuneration Committee Stakeholder Relationship Committee and Corporate Social Responsibility Committee with effect from April 01 2024 3. Other incidental and ancillary matters. Unaudited Results for the quarter and nine months ended on December 31, 2023 Outcome of Board meeting (As Per BSE Announcement dated on 03.02.2024)
30-Oct-2023 09-Nov-2023 ARIHANT CAPITAL MARKETS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September 2023. 2. Other incidental and ancillary matters. In continuation to our letter dated 30th October, 2023 and pursuant to Regulation 30 read with Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their meeting held today i.e. 09th November, 2023, inter-alia, approved and taken on record the following businesses: 1. Unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on 30th September, 2023 along with limited review report. 2. Took note of meeting of Debenture Issuance Committee of Board of Directors of Company. 3. Resignation of Mr. Tarun Goyal as Chief Financial Officer of the Company. 4. Appointment of Mr. Uttam Maheshwari as Chief Financial Officer of the Company (As per BSE Announcement Dated on 09/11/2023)
13-Jul-2023 22-Jul-2023 ARIHANT CAPITAL MARKETS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2023 inter alia to consider and approve Unaudited Standalone & Consolidated Financial Results of the Company for the first quarter ended on June 30 2023 and Other incidental and ancillary matter. ARIHANT CAPITAL MARKETS LIMITED has informed BSE about Board Meeting to be held on 22 Jul 2023 to consider financial statements for the period ended June 2023. Financial results / Other business. In continuation to our letter dated 13th July, 2023 and pursuant to Regulation 30 read with Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their meeting held today i.e. 22nd July, 2023, inter-alia, approved and taken on record the following businesses: 1. Unaudited standalone and consolidated financial results of the Company for the quarter ended on 30th June, 2023 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 along with the Limited Review Report issued by statutory auditor of the Company. 2. Other businesses incidental and ancillary to the Company''s business. Unaudited Financial Results for the quarter ended on June 30, 2023 (As Per BSE Announcement Dated on 22/07/2023)
08-Jun-2023 15-Jun-2023 ARIHANT CAPITAL MARKETS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/06/2023 inter alia to consider and approve 1. To issue secured unlisted redeemable non-convertible debentures (NCD) of the company on a private placement basis. 2. To consider any other matter with the permission of the Chairman if any. This is to inform that the Board of Directors of the Company, at its meeting held today, i.e. 15th June, 2023, has inter alia approved raising of funds through issuance of secured unlisted Non-Convertible Debentures (NCDs) upto Rs. 100 crores (Rupees One Hundred Crore only), in one or more tranches / series, on a private placement basis Details thereof as required under the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015 is enclosed herewith as Annexure A. (As per BSE Announcement Dated on 15/06/2023) The First Tranche of NCD is opened from 15th September,2023, will be closed on 20th September, 2023. (As Per BSE Announcement Dated on 16/09/2023)
09-May-2023 20-May-2023 ARIHANT CAPITAL MARKETS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2023 inter alia to consider and approve 1. Audited Standalone and Consolidated Financial Results of the Company for the financial year ending 31st March 2023 along with Auditors Report thereon; 2. To consider and recommend dividend if any on the equity shares of the Company for the financial year ending 31st March 2023 subject to the approval of the shareholders at the ensuing Annual General Meeting. 3. To consider matters relating to ensuing Annual General Meeting. 4. To consider any other matter with the permission of the Chairman if any. To consider and recommend dividend, if any, on the equity shares of the Company for the financial year ending 31st March, 2023 subject to the approval of the shareholders at the ensuing Annual General Meeting. (As Per BSE Announcement Dated on 13.05.2023) Board of Directors Recommended a dividend of 40% i.e. Rs. 0.40/- per equity share on face value of Rs. 1/- each for the financial year ended 31st March, 2023, subject to approval of the shareholders in the forthcoming Annual General Meeting of the Company. we wish to inform you that the Board of Directors of the Company in their meeting held today i.e. 20th May, 2023, inter-alia, approved the following businesses: 1. Audited Consolidated & Standalone Financial Results for quarter and year ended 31st March, 2023 along with the Statutory Auditor's Report thereon; A copy of the Audited Financial Results for quarter / year ended 31st March, 2023 along with the Statutory Auditor's Report thereon and declaration in respect of the Audit Report with unmodified opinion in terms of Regulation 33 of Listing Regulations is enclosed herewith. 2. Recommended a final dividend of 40% i.e. ? 0.40/- per equity share on face value of ? 1/- each for the financial year ended 31st March, 2023, subject to approval of the shareholders in the forthcoming Annual General Meeting of the Company. 3. Considered and approved the matters relating to ensuing Annual General Meeting. (As Per BSE Announcement Dated on 20.05.2023)

NIFTY:22,302.50  Up arrow
0.00(0.00%)
SENSEX:73,511.85  Up arrow
-45.46(-0.06%)

Product

Trading


Useful links

Who we are

Connect with us

Stay on top of the markets with our bite-sized newsletter delivered right to your Inbox!

footer-arrow-icon
appstore appstore

#1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Arihant Capital Markets Limited is a SEBI registered stock broker and depository participant. SEBI Registration number for NSE & BSE :- INZ000180939; NSDL - IN-DP-127-2015 DP ID-IN301983; CDSL DP ID-43000;NCDEX - 01274; MCX - 56565; AMFI - ARN 15114; SEBI Merchant Banking Reg. No. - MB INM000011070; SEBI Research Analyst Reg. No. - INH000002764. Registered Address: 6, Lad colony, Y.N. Road, Indore – 452001.Corporate office address: #1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Please carefully read the risk disclosure document as prescribed by SEBI, as well as the 'Do’s and Don’ts' provided by NSE, BSE, NCDEX, and MCX. If you have any complaints related to securities broking, kindly contact us at complaint@arihantcapital.com. For DP-related matters, please reach out to us at depository@arihantcapital.com.

If you want to register your complaints through SEBI Score Portal please click here. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

Investments in securities market are subject to market risks; read all the related documents carefully before investing.

Disclaimer: Arihant Capital Markets Limited is engaged in client based and proprietary trading on various exchanges.

  • ATTENTION INVESTORS :
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • For Stock Broking Transaction 'Prevent unauthorised transactions in your account - update your mobile numbers/email IDs with your stockbrokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.
  • For Depository Transaction 'Prevent Unauthorized Transactions in your demat account - Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day.
  • If you are subscribing to an IPO, there is no need to issue cheques. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.
  • Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Awareness regarding guidelines of margin collection:
1)Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
2)Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
3)Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.
Issued in the interest of investors

Dear Investor - As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor. https://www.bseipf.com/investors_education.html

Copyright © 2019 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)